Skip to main content
SpringerLink
Log in
Book cover

Reproduktionsmedizin pp 109–136Cite as

Ovarielle Stimulation

  • Chapter

  • 4358 Accesses

Zusammenfassung

Das Wirkprinzip der ovariellen Stimulation beruht auf einer indirekten oder direkten Erhöhung des Serum-FSHSpiegels. Das therapeutische Ziel der ovariellen Stimulation ist entweder die Unterstützung bzw. Herbeiführung eines Eisprungs bei Störung der Follikelreifung oder die Polyovulation zur Gewinnung von mehreren Eizellen für eine extrakorporale Verwendung.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Al-Azemi M, Kyrou D, Kolibianakis EM, Humaidan P, Van Vaerenberg I, Devroey P, Fatemi HM (2012) Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online Jan 24. [Epub ahead of print] PubMed PMID: 22377153

    Google Scholar 

  • Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM (2011) Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev May 11; (5): CD001750

    Google Scholar 

  • Amer SA, Li TC, Cooke ID (2003) A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy. Hum Reprod Aug; 18 (8): 1693–1698

    Article  CAS  Google Scholar 

  • Amer SA, Li TC, Metwally M, Emarh M, Ledger WL (2009) Randomized controlled trial comparing laparoscopic ovarian diathermy with clomiphene citrate as a first-line method of ovulation induction in women with polycystic ovary syndrome. Hum Reprod Jan; 24 (1): 219–225

    Article  CAS  Google Scholar 

  • Andersen AG, Als-Nielsen B, Hornnes PJ, Franch Andersen L (1995) Time interval from human chorionic gonadotrophin (HCG) injection to follicular rupture. Hum Reprod Dec; 10 (12): 3202–3205

    CAS  Google Scholar 

  • Nyboe Andersen A, Balen A, Platteau P, Devroey P, Helmgaard L, Arce JC (2008) Bravelle Ovulation Induction (BOI) Study Group. Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate. Hum Reprod 23 (6): 1424–1430

    Article  CAS  Google Scholar 

  • Andersen AN, Witjes H, Gordon K, Mannaerts B; Xpect investigators (2011) Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod 26 (12): 3413–3423

    Article  PubMed  CAS  Google Scholar 

  • Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, Verhoeff A, Macklon NS, Fauser BC (2007) Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod Apr; 22 (4): 980–988

    Article  Google Scholar 

  • Balasch J, Fábregues F, Creus M, Casamitjana R, Puerto B, Vanrell JA (2000) Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose stepup protocol. J Assist Reprod Genet Nov; 17 (10): 561–565

    Article  CAS  Google Scholar 

  • Balen A, Platteau P, Andersen AN, Devroey P, Helmgaard L, Arce JC; for the Bravelle Ovulation Induction (BOI) Study Group (2007) Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. Hum Reprod Jul; 22 (7): 1816–1823

    Article  PubMed  CAS  Google Scholar 

  • Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC (2003) Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab Sep; 88 (9): 4186–4192

    Article  CAS  Google Scholar 

  • Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O (2009) Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril Feb; 91 (2): 365–371

    Article  CAS  Google Scholar 

  • Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J, Pellicer A (2010) Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod Aug 25 (8): 2092–2100

    Article  CAS  Google Scholar 

  • Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E (2009) Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev Oct 7; (4): CD002249

    Google Scholar 

  • Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F (2010) The antral follicle count: practical recommendations for better standardization. Fertil Steril Aug; 94 (3): 1044–1051

    Article  Google Scholar 

  • Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ (2011) AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update Jan-Feb; 17 (1): 46–54

    Article  CAS  Google Scholar 

  • Cantineau AE, Cohlen BJ, Heineman MJ (2007) Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility. Cochrane Database Syst Rev Apr 18; (2): CD005356

    Google Scholar 

  • Cantineau AE, Janssen MJ, Cohlen BJ (2010) Synchronised approach for intrauterine insemination in subfertile couples. Cochrane Database Syst Rev Apr 14; (4): CD006942

    Google Scholar 

  • Cantineau AE, Cohlen BJ, Klip H, Heineman MJ; Dutch IUI Study Group Collaborators (2011) The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates—a randomized, double-blinded, placebo-controlled trial. Hum Reprod May; 26 (5): 1104–11

    Article  CAS  Google Scholar 

  • Casper RF, Mitwally MF (2011) Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol Dec; 54 (4): 685–95

    Article  Google Scholar 

  • Chan CC, Ng EH, Chan MM, Tang OS, Lau EY, Yeung WS, Ho PC (2003) Bioavailability of hCG after intramuscular or subcutaneous injection in obese and on-obese women. Hum Reprod Nov; 18 (11): 2294–2297

    Article  CAS  Google Scholar 

  • Chang P, Kenley S, Burns T, Denton G, Currie K, DeVane G, O’Dea L (2001) Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization embryo transfer. Fertil Steril 76: 67–74

    Article  PubMed  CAS  Google Scholar 

  • Chun E (2005) Severe OHSS can be prevented in GnRH antagonist protocol using GnRHa to trigger ovulation. Fertil Steril 84 (Suppl 1): S301 (P-149)

    Google Scholar 

  • Clark L, Stanger J, Brinsmead M (1991) Prolonged follicle stimulation decreases pregnancy rates after in vitro fertilization. Fertil Steril Jun; 55 (6): 1192–194

    CAS  Google Scholar 

  • Christin-Maitre S, Hugues JN; Recombinant FSH Study Group (2003) A comparative randomized multicentric study comparing the stepup versus step-down protocol in polycystic ovary syndrome. Hum Reprod Aug; 18 (8): 1626–1631

    Article  CAS  Google Scholar 

  • Couzinet B, Lestrat N, Brailly S, Forest M, Schaison G (1988) Stimulation of ovarian follicular maturation with pure follicle stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab. 66: 552–556

    Article  PubMed  CAS  Google Scholar 

  • Crosignani PG, Somigliana E; Intrauterine Insemination Study Group (2007) Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial. Hum Reprod Feb; 22 (2): 500–505

    Article  CAS  Google Scholar 

  • D’Angelo A, Brown J, Amso NN (2011) Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev Jun 15; (6): CD002811

    Google Scholar 

  • Daya S (2007) WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev Jul 18; (1): CD001299

    Google Scholar 

  • Devroey P, Boostanfar R, Koper N P, Mannaerts BM, Ijzerman-Boon PC, Fauser BC (2009a) A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod 24 (12): 3063–3072

    Article  CAS  Google Scholar 

  • Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomás C, Fauser BC (2009b) Improving the patient’s experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod Apr; 24 (4): 764–74

    Article  CAS  Google Scholar 

  • Dickey RP, Taylor SN, Curole DN, Rye PH, Pyrzak R (1996) Incidence of spontaneous abortion in clomiphene pregnancies. Hum Reprod 11: 2623–2628

    Article  PubMed  CAS  Google Scholar 

  • Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T, Krebs D, Klingmüller D(1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod May; 9 (5): 788–91

    CAS  Google Scholar 

  • Driscoll GL, Tyler JP, Hangan JT, Fisher PR, Birdsall MA, Knight DC (2000) A prospective, randomized, controlled, double-blind, doubledummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Hum Reprod 15: 1305–10

    Article  PubMed  CAS  Google Scholar 

  • Dubourdieu S, Le Nestour E, Spitz IM, Charbonnel B, Bouchard P (1993) The combination of gonadotrophin-releasing hormone (GnRH) antagonist and pulsatile GnRH normalizes luteinizing hormone secretion in polycystic ovarian disease but fails to induce follicular maturation. Hum Reprod Dec; 8 (12): 2056–60

    CAS  Google Scholar 

  • Duijkers IJ, Klipping C, Boerrigter PJ, Machielsen CS, De Bie JJ, Voortman G (2002) Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females. Hum Reprod Aug; 17 (8): 1987–1993

    Article  CAS  Google Scholar 

  • Eijkemans MJ, Imani B, Mulders AG, Habbema JD, Fauser BC (2003) High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod Nov; 18 (11): 2357–2362

    Article  Google Scholar 

  • Elkind-Hirsch KE, Phillips K, Bello SM, McNicho M, de Ziegler D (2002) Sequential hormonal supplementation with vaginal estradiol and progesterone gel corrects the ffect of clomiphene on the endometrium in oligo-ovulatory women. Hum Reprod Feb; 17 (2): 295–298

    Article  CAS  Google Scholar 

  • European Recombinant Human LH Study Group (1998) Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab May; 83 (5): 1507–1514

    Article  Google Scholar 

  • Farhi J, Orvieto R, Homburg R (2010a) Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding,achieves comparable treatment characteristics and outcome. Fertil Steril Apr; 93 (6): 2077–2079

    Article  Google Scholar 

  • Farhi J, Orvieto R, Gavish O, Homburg R (2010b) The association between follicular size on human chorionic gonadotropin day and pregnancy rate in clomiphene citrate treated polycystic ovary syndrome patients. Gynecol EndocrinolJul; 26 (7): 546–548

    Article  CAS  Google Scholar 

  • Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P (2007) Laparoscopic ›drilling‹ by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev Jul 18; (3): CD001122

    Google Scholar 

  • Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, van Hooren HG (2002) Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab Feb; 87 (2): 709–715

    Article  CAS  Google Scholar 

  • Fauser BC, Nargund G, Andersen AN, Norman R, Tarlatzis B, Boivin J, Ledger W (2010) Mild ovarian stimulation for IVF: 10 years later. Hum Reprod Nov; 25 (11): 2678–2684

    Article  Google Scholar 

  • Felberbaum RE, Reissmann T, Küpker W, Bauer O, al Hasani S, Diedrich C, Diedrich K (1995) Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. Eur J Obstet Gynecol Reprod Biol Aug; 61 (2): 151–155

    Article  CAS  Google Scholar 

  • Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, Tabarelli De Fatis C, Pocognoli P, Cantelli B, Boschi S (2001) Luteinzing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J Clin Endocrinol Metab Jan; 86 (1): 337–343

    Article  CAS  Google Scholar 

  • Flyckt RL, Goldberg JM (2011) Laparoscopic ovarian drilling for clomiphene- resistant polycystic ovary syndrome. Semin Reprod Med Mar; 29 (2): 138–146

    Google Scholar 

  • Freiesleben NL, Lossl K, Bogstad J, Bredkjaer HE, Toft B, Loft A, Bangsboll S, Pinborg A, Budtz-Jørgensen E, Andersen AN (2008) Predictors of ovarian response in intrauterine insemination patients and development of a dosage nomogram. Reprod Biomed Online Nov; 17 (5): 632–641

    Article  CAS  Google Scholar 

  • Galazis N, Zertalis M, Haoula Z, Atiomo W (2011) Is ultrasound monitoring of the ovaries during ovulation induction by clomiphene citrate essential? A systematic review. J Obstet Gynaecol Oct; 31 (7): 566–71

    Article  CAS  Google Scholar 

  • Gonen Y, Balakier H, Powell W, Casper RF (1990) Use of gonadotropinreleasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab Oct; 71 (4): 918–922

    Article  CAS  Google Scholar 

  • Griesinger G, Felberbaum RE, Schultze-Mosgau A, Diedrich K (2004) Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents? Drugs 64 (6): 563–575

    Article  PubMed  CAS  Google Scholar 

  • Griesinger G, Diedrich K, Tarlatzis B, Kolibianakis EM (2006) GnRH-antagonists in ovarian stimulation for IVF in patients with [1] poor response to gonadotrophins, [2] polycystic ovary syndrome, and [3] risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 13 (5): 628–638

    Article  PubMed  CAS  Google Scholar 

  • Griesinger G, von Otte S, Schroer A, Ludwig AK, Diedrich K, Al-Hasani S, Schultze-Mosgau A (2007) Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept udy. Hum Reprod May; 22 (5): 1348–1352

    Article  CAS  Google Scholar 

  • Griesinger G, von Otte S, Schultze-Mosgau A, Diedrich K, Schröer A (2009) Follicular and endocrine response to anastrozole versus clomiphene citrate administered in follicular phase to normoovulatory women: a randomized comparison. Fertil Steril May; 91 (5): 1831–1836

    Article  CAS  Google Scholar 

  • Griesinger G, Shapiro DB, Kolibianakis EM, Witjes H, Mannaerts BM (2011a) No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part II, recombinant FSH. Reprod Biomed Online Oct; 23 (4): 457–65

    Article  CAS  Google Scholar 

  • Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S (2011b) Ovarian hyperstimulation syndrome prevention by gonadotropin- releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a »freeze-all« strategy: a prospective multicentric study. Fertil Steril May; 95 (6): 2029–33, 2033.e1

    Article  CAS  Google Scholar 

  • He D, Jiang F (2011) Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome. Reprod Biomed Online Jul; 23 (1): 91–96

    Article  CAS  Google Scholar 

  • Healy DL, Trounson AO, Nyboe Andersen A (1994) Female infertility: causes and treatment. Lancet 343: 1539–1544

    Article  PubMed  CAS  Google Scholar 

  • Hendriks ML, Van Der Valk P, Lambalk CB, Broeckaert MA, Homburg R, Hompes PG (2010) Extensive tissue damage of bovine ovaries after bipolar ovarian drilling compared to monopolar electrocoagulation or carbon dioxide laser. Fertil Steril Feb; 93 (3): 969–975

    Article  Google Scholar 

  • Hillier SG (1993) Ovarian stimulation with recombinant gonadotrophins: LH as adjunct to FSH. In Jacobs HS (ed.) The new frontier in ovulation induction. Parthenon, Carnforth, pp. 39–47

    Google Scholar 

  • Hillier SG, Whitelaw PF, Smyth CD (1994) Follicular oestrogen synthesis: the ‘two-cell, two-gonadotropin’ model revisited. Mole Cell Endocrinol 100: 51–54

    Article  CAS  Google Scholar 

  • Hohmann FP, Laven JS, Mulders AG, Oberyé JJ, Mannaerts BM, de Jong FH, Fauser BC (2005) LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome. J Endocrinol Invest Dec; 28 (11): 990–997

    CAS  Google Scholar 

  • Homburg R (2005) Clomiphene citrate – end of an era? A mini-review. Hum Reprod Aug; 20 (8): 2043–2051

    Article  CAS  Google Scholar 

  • Homburg R, Howles CM (1999) Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Hum Reprod Update 5 (5): 493–499

    Article  PubMed  CAS  Google Scholar 

  • Homburg R, Hendriks ML, König TE, Anderson RA, Balen AH, Brincat M, Child T, Davies M, D‘Hooghe T, Martinez A, Rajkhowa M, Rueda- Saenz R, Hompes P, Lambalk CB (2012) Clomifene citrate or lowdose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study. Hum Reprod Feb; 27 (2): 468–473

    Article  CAS  Google Scholar 

  • Hughes E, Brown J, Collins JJ, Vanderkerchove P (2010) Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev Jan 20; (1): CD000057

    Google Scholar 

  • Hugues JN, Soussis J, Calderon I, Balasch J, Anderson RA, Romeu A (2005) Recombinant LH Study Group. Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study. Hum Reprod 20 (3): 629–635

    Article  PubMed  CAS  Google Scholar 

  • Humaidan P, Papanikolaou EG, Kyrou D, Alsbjerg B, Polyzos NP, Devroey P, Fatemi HM (2012) The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. Reprod Biomed Online Feb; 24 (2): 134–141

    Article  CAS  Google Scholar 

  • Imani B, Eijkemans MJ, Faessen GH, Bouchard P, Giudice LC, Fauser BC (2002a) Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril. Jan; 77 (1): 83–90

    Article  Google Scholar 

  • Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC (2002b) A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril Jan; 77 (1): 91–7

    Article  Google Scholar 

  • Kol S (2004) Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril Jan; 81 (1): 1–5

    Article  CAS  Google Scholar 

  • Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER (2005) Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod Mar; 20 (3): 611–615

    Article  CAS  Google Scholar 

  • Kolibianakis EM, Griesinger G, Venetis CA (2012) GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data. Hum Reprod Update 18 (2): 228–229

    Article  PubMed  CAS  Google Scholar 

  • Kolibianakis EM, Zikopoulos KA, Fatemi HM, Osmanagaoglu K, Evenpoel J, Van Steirteghem A, Devroey P (2004a) Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reprod Biomed Online Jan; 8 (1): 115–8

    Article  CAS  Google Scholar 

  • Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P (2004b) Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril Jul; 82 (1): 102–107

    Article  CAS  Google Scholar 

  • Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G (2006) Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 12 (6): 651–671

    Article  PubMed  CAS  Google Scholar 

  • Kolibianakis EM, Griesinger G, Venetis CA (2012) GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data. Hum Reprod Update 2012 Mar; 18 (2): 228–229

    Google Scholar 

  • Kosmas IP, Tatsioni A, Fatemi HM, Kolibianakis EM, Tournaye H, Devroey P (2007) Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene itrate: a meta-analysis. Fertil Steril Mar; 87 (3): 607–612

    Article  PubMed  CAS  Google Scholar 

  • Kosmas IP, Tatsioni A, Kolibianakis EM, Verpoest W, Tournaye H, Van Der Elst J, Devroey P (2008) Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril Aug; 90 (2): 367–372

    Article  Google Scholar 

  • Kousta E, White DM, Franks S (1997) Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update Jul-Aug; 3 (4): 359–365

    Article  CAS  Google Scholar 

  • Kyrou D, Popovic-Todorovic B, Fatemi HM, Bourgain C, Haentjens P, Van Landuyt L, Devroey P (2009) Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? Hum Reprod Nov; 24 (11): 2902–2909

    Article  PubMed  CAS  Google Scholar 

  • Kyrou D, Fatemi HM, Tournaye H, Devroey P (2010) Luteal phase support in normo-ovulatory women stimulated with clomiphene citrate for intrauterine insemination: need or habit? Hum Reprod Oct; 25 (10): 2501–2506

    Article  PubMed  CAS  Google Scholar 

  • Labarta E, Martínez-Conejero JA, Alamá P, Horcajadas JA, Pellicer A, Simón C, Bosch E (2011) Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod Jul; 26 (7): 1813–1825

    Article  CAS  Google Scholar 

  • la Cour Freiesleben N, Lossl K, Bogstad J, Bredkjaer HE, Toft B, Rosendahl M, Loft A, Bangsboll S, Pinborg A, Nyboe Andersen A (2009) Individual versus standard dose of rFSH in a mild stimulation protocol for intrauterine insemination: a randomized study. Hum Reprod Oct; 24 (10): 2523–2530

    Article  CAS  Google Scholar 

  • La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, Volpe A (2007) Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod Mar; 22 (3): 766–771

    Article  PubMed  CAS  Google Scholar 

  • Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC,Leppert PC, Myers ER; Cooperative Multicenter Reproductive Medicine Network (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med Feb 8; 356 (6): 551–566

    Article  CAS  Google Scholar 

  • López E, Gunby J, Daya S, Parrilla JJ, Abad L, Balasch J (2004) Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy. Reprod Biomed Online Oct; 9 (4): 382–390

    Article  Google Scholar 

  • Loumaye E (1990) The control of endogenous secretion of LH by gonadotrophin- releasing hormone agonists during ovarian hyperstimulationfor in-vitro fertilization and embryo transfer. Hum Reprod May; 5 (4): 357–376

    CAS  Google Scholar 

  • Ludwig M, Katalinic A, Banz C, Schröder AK, Löning M, Weiss JM, Diedrich K (2002) Tailoring the GnRH antagonist cetrorelix acetate to individual patients’ needs in ovarian stimulation for IVF: results of a prospective, randomized study. Hum Reprod Nov; 17 (11): 2842–2845

    Article  CAS  Google Scholar 

  • Mannaerts BM, Rombout F, Out HJ, Coelingh Bennink H (1996) Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy. Hum Reprod Update Mar-Apr; 2 (2): 153–161

    Article  PubMed  CAS  Google Scholar 

  • Mannaerts B on behalf The corifollitropin alfa Ensure study group (2010) Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women. Reproductive BioMedicine Online (2010) 21, 66–76

    Article  CAS  Google Scholar 

  • Martinez AR, Bernardus RE, Voorhorst FJ, Vermeiden JP, Schoemaker J (1991) Pregnancy rates after timed intercourse or intrauterine insemination after human menopausal gonadotropin stimulation of normal ovulatory cycles: a controlled study. Fertility and Sterility 55 (2): 258–265

    PubMed  CAS  Google Scholar 

  • Matorras R, Ramón O, Expósito A, Corcóstegui B, Ocerin I, Gonzalez- Lopera S, Rodríguez-Escudero FJ (2006) Gn-RH antagonists in intrauterine insemination: the weekend-free protocol. J Assist Reprod Genet Feb; 23 (2): 51–54

    Article  Google Scholar 

  • Nargund G, Reid F, Parsons J (2001) Human chorionic gonadotropinto- oocyte collection interval in a superovulation IVF program. A prospective study. J Assist Reprod Genet 18 (2): 87–90

    Article  PubMed  CAS  Google Scholar 

  • Nargund G, Fauser BC, Macklon NS, Ombelet W, Nygren K, Frydman R; Rotterdam ISMAAR Consensus Group on Terminology for Ovarian Stimulation for IVF (2007) The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod Nov; 22 (11): 2801–2804

    Article  CAS  Google Scholar 

  • Nahuis MJ, Kose N, Bayram N, van Dessel HJ, Braat DD, Hamilton CJ, Hompes PG, Bossuyt PM, Mol BW, Van Der Veen F, van Wely M (2011) Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins. Hum Reprod Jul; 26 (7): 1899–904

    Article  CAS  Google Scholar 

  • Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, Mitchell P, Ambrose P, Fleming R (2009) Anti-Müllerian hormonebased approach to controlled ovarian stimulation for assisted conception. Hum Reprod Apr; 24 (4): 867–875

    Article  CAS  Google Scholar 

  • Norman RJ, Zegers-Hochschild F, Salle BS, Elbers J, Heijnen E, Marintcheva- Petrova M, Mannaerts B; Trust Investigators (2011) Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity. Hum Reprod Aug 26 (8): 2200–2208

    Article  CAS  Google Scholar 

  • Nugent D, Vandekerckhove P, Hughes E, Arnot M, Lilford R (2000) Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev ; (4): CD000410

    Google Scholar 

  • Olivennes F, Howles CM, Borini A, Germond M, Trew G, Wikland M, Zegers-Hochschild F, Saunders H, Alam V; CONSORT Study Group (2009) Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study. Reprod Biomed Online Feb; 18 (2): 195–204

    Article  CAS  Google Scholar 

  • Olivius C, Friden B, Borg G, Bergh C (2004) Why do couples discontinue in vitro fertilization treatment? A cohort study. Fertil Steril Feb; 81 (2): 258–261

    Article  Google Scholar 

  • Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P (2006) Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril Jan; 85 (1): 112–120

    Article  CAS  Google Scholar 

  • Pauli JM, Raja-Khan N, Wu X, Legro RS (2011) Current perspectives of insulin resistance and polycystic ovary syndrome. Diabet Med Dec; 28 (12): 1445–54

    Article  CAS  Google Scholar 

  • Polyzos NP, Tzioras S, Badawy AM, Valachis A, Dritsas C, Mauri D (2009) Aromatase inhibitors for female infertility: a systematic review of the literature. Reprod Biomed Online Oct; 19 (4): 456–471

    Article  CAS  Google Scholar 

  • Popovic-Todorovic B, Loft A, Bredkjaeer HE, Bangsbøll S, Nielsen IK, Andersen AN (2003a) A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a ‘standard’ dose of 150 IU/day in ‘standard’ patients undergoing IVF/ICSI treatment. Hum Reprod Nov; 18 (11): 2275–2282

    Article  CAS  Google Scholar 

  • Popovic-Todorovic B, Loft A, Lindhard A, Bangsbøll S, Andersson AM, Andersen AN (2003b) A prospective study of predictive factors of ovarian response in ‘standard’ IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod Apr; 18 (4): 781–787

    Article  CAS  Google Scholar 

  • Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS (1984) Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet ii (8414): 1284–1285

    Google Scholar 

  • Randall JM, Templeton A (1992) Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril 56: 465–468

    Google Scholar 

  • Reefhuis J, Honein MA, Schieve LA, Rasmussen SA (2011) National Birth Defects Prevention Study. Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997–2005. Hum Reprod Feb; 26 (2): 451–7

    Article  PubMed  CAS  Google Scholar 

  • Richmond JR, Deshpande N, Lyall H, Yates RW, Fleming R (2005) Follicular diameters in conception cycles with and without multiple pregnancy after stimulated ovulation induction. Hum Reprod Mar; 20 (3): 756–760

    Google Scholar 

  • Rombauts L (2007) Is there a recommended maximum starting dose of FSH in IVF? J Assist Reprod Genet Aug; 24 (8): 343–349

    Article  PubMed  Google Scholar 

  • Schill T (2011) Daten zur konservativen Fertiltätstherapie. DVR Kongress 2011

    Google Scholar 

  • Schmidt TW, Maier DB, Nulsen JC,Benadiva CA (2004) Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization. Fertil Steril 82 (4): 841–846

    Article  PubMed  CAS  Google Scholar 

  • Schoot DC, Hop WC, de Jong FH, van Dessel TJ, Fauser BC (1995) Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome. Fertil Steril Dec; 64 (6): 1081–7

    CAS  Google Scholar 

  • Shoham Z, Balen A, Patel A, Jacobs HS (1991) Results of ovulation induction using human menopausal gonadotropin or purified follicle- stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril Dec; 56 (6): 1048–1053

    CAS  Google Scholar 

  • Steptoe PC, Edwards RG (1978) Birth after the reimplantation of a human embryo. Lancet ii: 366

    Google Scholar 

  • Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A (2011) Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 26: 1768–1774

    Article  PubMed  Google Scholar 

  • Tan SL, Balen A, el Hussein E, Mills C, Campbell S, Yovich J, Jacobs HS (1992) A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization. Fertil Steril Jun; 57 (6): 1259–1264

    PubMed  CAS  Google Scholar 

  • Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH (2010) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev Jan 20; (1): CD003053

    Google Scholar 

  • Tarlatzis B, Griesinger G, Leader A, Rombauts R, IJzerman-Boon P, Mannaerts B, on behalf of all investigators participating in the Engage, Ensure or Trust trials (2012) Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or  ecombinant FSH. Reprod Biomed Online 24 (4): 410–419, Epub 2012 Jan 24

    Article  PubMed  CAS  Google Scholar 

  • Tavaniotou A, Albano C, Smitz J, Devroey P (2002) Impact of ovarian stimulation on corpus luteum function and embryonic implantation.J Reprod Immunol May-Jun; 55 (1–2): 123–130

    Article  CAS  Google Scholar 

  • The European Recombinant LH Study Group. Recombinant Human Luteinizing Hormone Is as Effective as, But Safer Than, Urinary Human Chorionic Gonadotropin in Inducing Final Follicular Maturation and Ovulation in in Vitro Fertilization Procedures: Results of a Multicenter Double-Blind Study. JCEM 2001; 86 (6): 2607–2618

    Google Scholar 

  • Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod Mar; 23 (3): 462–477. Erratum in: Hum Reprod 2008 Jun; 23 (6): 1474

    Article  Google Scholar 

  • Thornton SJ, Pantos C, Speirs A, Johnston I (1990) Human chorionic gonadotropin to oocyte retrieval interval in in vitro fertilization- -how critical is it ? Fertil Steril Jan; 53 (1): 177–179

    PubMed  CAS  Google Scholar 

  • Tredway DR, Schertz JC (2011) Anastrozole versus clomiphene citrate: which is better for ovulation induction? Fertil Steril Apr; 95 (5): 1549–1551

    Article  PubMed  CAS  Google Scholar 

  • Trounson AO, Leeton JF, Wood C et al. (1981) Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science May 8; 212 (4495): 681–2

    CAS  Google Scholar 

  • Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, Librach C, Greenblatt E, Casper RF (2006) Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril Jun; 85 (6): 1761–1765

    Article  CAS  Google Scholar 

  • Van Hooff MH, Alberda AT, Huisman GJ, Zeilmaker GH, Leerentveld RA (1993) Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study. Hum Reprod 8: 369–373

    PubMed  Google Scholar 

  • van Rumste MM, Custers IM, Van Der Veen F, van Wely M, Evers JL, Mol BW (2008) The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. Hum Reprod Update Nov-Dec; 14 (6): 563–570

    Article  Google Scholar 

  • van Santbrink EJ, Eijkemans MJ, Macklon NS, Fauser BC (2002) FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility. Eur J Endocrinol Aug; 147 (2): 223–226

    Article  Google Scholar 

  • van Weissenbruch MM, Schoemaker HC, Drexhage HA, Schoemaker J (1993) Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease. Hum Reprod Jun; 8 (6): 813–821

    Google Scholar 

  • van Wely M, Bayram N, Van Der Veen F, Bossuyt PM (2004) An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod Aug; 19 (8): 1741–1745

    Article  CAS  Google Scholar 

  • van Wely M, Fauser BC, Laven JS, Eijkemans MJ, Van Der Veen F (2006) Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome. Fertil Steril 86 (6): 1710–1715

    Article  PubMed  CAS  Google Scholar 

  • White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C, Hamilton-Fairley D, Franks S (1996) Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab Nov; 81 (11): 3821–3824

    Article  CAS  Google Scholar 

  • Wikland M, Borg J, Forsberg AS, Jakobsson AH, Svalander P, Waldenström U (1995) Human chorionic gonadotrophin self-administered by the subcutaneous route to induce oocyte maturation in an in-vitro fertilization and embryo transfer programme. Hum Reprod Jul; 10 (7): 1667–1670

    CAS  Google Scholar 

  • Youssef MA, Van Der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, Khattab SM, van Wely M (2011) Gonadotropinreleasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev Jan 19; (1): CD008046

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sektion für gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinikum Schleswig-Holstein Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck

    Prof. Dr. med. G. Griesinger

Authors
  1. Prof. Dr. med. G. Griesinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinikum Schleswig-Holstein, Schleswig-Holstein, Campus Lübeck

    Klaus Diedrich  & Georg Griesinger  & 

  2. amedes, Zentrum für Endokrinologie, Kinderwunsch und Pränatale Medizin im Barkhof, Hamburg

    Michael Ludwig

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Griesinger, G. (2013). Ovarielle Stimulation. In: Diedrich, K., Ludwig, M., Griesinger, G. (eds) Reproduktionsmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30181-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-30181-0_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-30180-3

  • Online ISBN: 978-3-642-30181-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation